Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: Obinutuzumab Containing Conditioning Regimen for CLL Patients and Patients With Richter`s Transformation Requiring an Allogeneic Stem Cell Transplantation
Brief Summary: The primary objective of the study is to evaluate the feasibility, efficacy and safety of an obinutuzumab containing conditioning regimen for poor risk CLL patients and patients with Richter`s transformation requiring an allogeneic stem cell transplantation.